Premium
Diagnostic performance of CT, gadoxetate disodium‐enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta‐analysis
Author(s) -
Choi Sang Hyun,
Kim So Yeon,
Park Seong Ho,
Kim Kyung Won,
Lee Ja Youn,
Lee Seung Soo,
Lee MoonGyu
Publication year - 2018
Publication title -
journal of magnetic resonance imaging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.563
H-Index - 160
eISSN - 1522-2586
pISSN - 1053-1807
DOI - 10.1002/jmri.25852
Subject(s) - medicine , meta analysis , radiology , magnetic resonance imaging , positron emission tomography , nuclear medicine , confidence interval , diagnostic accuracy , computed tomography , pathology
Background Imaging studies, including computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET), have an essential role in the detection and localization of colorectal liver metastasis (CRLM). Purpose To systematically determine the diagnostic accuracy of multidetector row CT (MDCT), gadoxetate disodium‐enhanced MRI, and PET/CT for diagnosing CRLM and the sources of heterogeneity between the reported results. Study Type Systematic review and meta‐analysis. Subjects In all, 2151 lesions in CT studies, 2301 lesions in MRI studies, 1846 lesions in PET/CT studies, Field Strength 1.5T and 3.0T. Assessment We identified research studies that investigated MDCT, gadoxetate disodium‐enhanced MRI, and PET/CT to diagnose CRLM by performing a systematic search of PubMed MEDLINE and EMBASE. Study quality was assessed using Quality Assessment of Diagnostic Accuracy Studies (QUADAS‐2). Statistical Tests According to the types of imaging tests, study heterogeneity and the threshold effect were analyzed and the meta‐analytic summary of sensitivity and specificity were estimated. Meta‐regression analysis was performed to further investigate study heterogeneity. Results Of the 860 articles screened, we found 36 studies from 24 articles reporting a diagnosis of CRLM (11 CT studies, 12 MRI studies, and 13 PET/CT studies). The meta‐analytic summary sensitivity for CT, MRI, and PET/CT were 82.1% (95% confidence interval [CI], 74.0–88.1%), 93.1% (95% CI, 88.4–96.0%), and 74.1% (95% CI, 62.1–83.3%), respectively. The meta‐analytic summary specificity for CT, MRI, and PET/CT were 73.5% (95% CI, 53.7–86.9%), 87.3% (95% CI, 77.5–93.2%), and 93.9% (95% CI, 83.9–97.8%), respectively. There was no threshold effect in any of the imaging tests. Neoadjuvant chemotherapy significantly decreased the sensitivity of CT and MRI ( P < 0.01), although it did not significantly affect the sensitivity of PET/CT. The study design, type of reference standard, and study quality also affected the diagnostic performances of imaging studies. Data Conclusion Despite the heterogeneous accuracy between studies, gadoxetate disodium‐enhanced MRI showed the highest sensitivity, and gadoxetate disodium‐enhanced MRI and PET/CT had similar specificities for diagnosing CRLM. Level of Evidence : 3 Technical Efficacy : Stage 2 J. Magn. Reson. Imaging 2018;47:1237–1250.